- Home
- NXRT vs QURE Comparison
NXRT vs QURE Comparison
Compare NXRT & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXRT
- QURE
- Stock Information
- Founded
- NXRT 2014
- QURE 1998
- Country
- NXRT United States
- QURE Netherlands
- Employees
- NXRT N/A
- QURE N/A
- Industry
- NXRT Real Estate Investment Trusts
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- NXRT Real Estate
- QURE Health Care
- Exchange
- NXRT Nasdaq
- QURE Nasdaq
- Market Cap
- NXRT 859.4M
- QURE 725.4M
- IPO Year
- NXRT N/A
- QURE 2007
- Fundamental
- Price
- NXRT $34.89
- QURE $15.15
- Analyst Decision
- NXRT Hold
- QURE Strong Buy
- Analyst Count
- NXRT 6
- QURE 10
- Target Price
- NXRT $41.88
- QURE $37.20
- AVG Volume (30 Days)
- NXRT 158.5K
- QURE 1.0M
- Earning Date
- NXRT 07-29-2025
- QURE 07-29-2025
- Dividend Yield
- NXRT 5.88%
- QURE N/A
- EPS Growth
- NXRT N/A
- QURE N/A
- EPS
- NXRT N/A
- QURE N/A
- Revenue
- NXRT $255,529,000.00
- QURE $20,201,000.00
- Revenue This Year
- NXRT N/A
- QURE N/A
- Revenue Next Year
- NXRT $5.28
- QURE $278.91
- P/E Ratio
- NXRT N/A
- QURE N/A
- Revenue Growth
- NXRT N/A
- QURE 6.30
- 52 Week Low
- NXRT $30.98
- QURE $4.45
- 52 Week High
- NXRT $48.37
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- NXRT 55.99
- QURE 46.89
- Support Level
- NXRT $33.58
- QURE $13.61
- Resistance Level
- NXRT $34.88
- QURE $15.84
- Average True Range (ATR)
- NXRT 0.69
- QURE 0.70
- MACD
- NXRT 0.13
- QURE -0.01
- Stochastic Oscillator
- NXRT 83.83
- QURE 31.51
About NXRT NexPoint Residential Trust Inc.
NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.